Compare INBK & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INBK | QSI |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | United States |
| Employees | 355 | 145 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.3M | 194.8M |
| IPO Year | N/A | N/A |
| Metric | INBK | QSI |
|---|---|---|
| Price | $25.36 | $0.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $23.25 | $1.00 |
| AVG Volume (30 Days) | 54.2K | ★ 5.7M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $279.34 | N/A |
| Revenue Next Year | $12.97 | $618.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.05 | $0.69 |
| 52 Week High | $28.51 | $3.10 |
| Indicator | INBK | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 68.25 | 47.13 |
| Support Level | $21.25 | $0.89 |
| Resistance Level | N/A | $1.10 |
| Average True Range (ATR) | 1.09 | 0.08 |
| MACD | 0.17 | -0.00 |
| Stochastic Oscillator | 90.77 | 14.98 |
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.